Sr. No. |
Name |
CAS No. |
BP
Code |
USP
Code |
EP
Code |
WHO
Code |
|
ALLOPURINOL* |
1 |
5-Amino-1H-pyrazole-4-carboxamide |
5334-31-6 |
- |
A |
A |
- |
2 |
5-(formylamino)-1H-pyrazole-4-carboxamide |
22407-20-1 |
- |
B |
B |
- |
3 |
Ethyl-5-amino-1H-pyrazole-4-carboxylate |
103259-35-4 |
- |
D |
D |
- |
4 |
Ethyl-5-(formylamino)-1H-pyrazole-4-carboxylate |
31055-19-3 |
- |
E |
E |
- |
5 |
3-Amino-4-carboxamide pyrazole hemisulfate (ASP) |
27511-79-1 |
- |
- |
- |
- |
6 |
3-Morphololino-2-cyanoacrylamide (MCA) |
25229-97-4 |
- |
- |
- |
- |
|
AMODIAQUINE HYDROCHLORIDE* |
7 |
7-chloro-4-(4-hydroxy phenyl amino)-Quinoline |
- |
- |
- |
- |
- |
8 |
N-{3-[(diethylamino)methyl]-4-hydroxyphenyl}-acetamide or Mannich Base |
- |
- |
- |
- |
- |
9 |
N-(4-hydroxyphenyl)-acetamide [Paracetamol] |
103-90-2 |
- |
- |
- |
- |
10 |
4,7-Dichloroquinoline |
86-98-6 |
- |
- |
- |
- |
|
ARTEMETHER*/ARTESUNATE*/DIHYDROARTEMISININ* |
11 |
Artemisinin |
63968-64-9 |
- |
- |
- |
- |
12 |
Dihydroartemisinin |
81496-81-3 |
- |
- |
- |
- |
13 |
α - Artemether |
71939-51-0 |
- |
- |
- |
- |
|
BISOPROLOL FUMARATE* |
14 |
(RS)-1-(4-Hydroxymethylphenoxy)-3-isopropylaminopropan-2-ol or Bisoprolol impurity A |
62572-93-4 |
- |
- |
A |
- |
15 |
(RS)-1-Isopropylamino-3-[4-(2-propoxyethoxymethyl)phenoxy] propan-2-ol or Bisoprolol impurity B |
1447715-44-7 |
- |
- |
B |
- |
16 |
4[(2Isopropoxyethoxy) Methyl] Phenol (BS-1) |
177034-57-0 |
- |
- |
B |
- |
17 |
2-[[4-(2-isopropoxyethoxy)methyl]-phenoxymethyl]oxirane (BS-2) |
66722-57-4 |
- |
- |
- |
- |
|
4,7-DICHLOROQUINOLINE |
18 |
4,5-Dichloroquinoline or 4,5-DCQ |
21617-18-5 |
- |
- |
- |
- |
19 |
7-Chloro-4-ethoxy quinoline |
5448-52-2 |
- |
- |
- |
- |
20 |
7-Chloro-4-hydroxyquinoline OR 7-chloroquinolin-4-ol |
86-99-7 |
- |
- |
- |
- |
21 |
5-Chloro-4-hydroxyquinoline OR 5-chloroquinolin-4-ol |
101774-49-6 |
- |
- |
- |
- |
|
FUROSEMIDE* |
22 |
2,4 dichloro-5-Sulphamoyl benzoic acid [Lasamide] |
2736-23-4 |
B |
- |
B |
- |
23 |
2-amino-4-chloro-5-Sulphamoyl benzoic acid |
3086-91-7 |
C |
- |
C |
- |
24 |
2,4-dichlorobenzoic acid |
50-84-0 |
E |
- |
E |
- |
25 |
4-chloro-5-sulfamoylanthranilic acid |
3086-91-7 |
- |
B |
- |
- |
|
HYDROXYCHLOROQUINE SULPHATE* |
26 |
4,7-Dichloroquinoline |
86-98-6 |
- |
G |
- |
- |
27 |
Mixture of diastereomers of 4-[(7-chloroquinolin-4-yl)amino]-N-ethyl-N-(hydroxyethyl) pentan-1-amine N-oxide orimpurity A |
- |
- |
A |
- |
- |
28 |
2-[[(4RS)-4-[(7-chloroquinolin-4-yl)amino]pentyl]-(ethyl)amino]ethyl hydrogen sulfate or impurity B |
103152-84-7 |
- |
B |
- |
- |
29 |
7-chloro-4-[(2RS)-2-methylpyrrolidin-1-yl)quinoline or impurity F |
6281-58-9 |
- |
F |
- |
- |
30 |
Ethyl mono Ethanol amine (EMEA) |
110-73-6 |
- |
- |
- |
- |
31 |
2-((4-aminopentyl)(ethyl)amino)ethanol or Hydroxy novaldiamine (HNDA) |
69559-11-1 |
- |
- |
- |
- |
|
LUMEFANTRINE* |
32 |
2,7-dichloro-4-fluorenyl ketone |
7012-16-0 |
- |
- |
- |
- |
33 |
2-chloro-1-(2,7-dichloro-9H-fluoren-4-yl)-ethanone |
131023-37-5 |
- |
- |
- |
- |
34 |
2-dibutylamino-1-(2,7-dichloro-9H-fluoren-4-yl)-ethanol |
69759-61-1 |
- |
- |
- |
- |
35 |
4-Chloro benzaldehyde |
104-88-1 |
- |
- |
- |
- |
36 |
Desbutyl Lumefantrine or (Z)-2-(butylamino)-1-(2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl)ethanol |
355841-11-1 |
- |
A |
- |
- |
37 |
Epoxide or 2-Chloro-1-(2, 7-Dichloro-9h-fluoren-4-yl) Ethanone |
53221-14-0 |
- |
- |
- |
- |
|
NIMESULIDE* |
38 |
N-(2,4-Dinitro-6-phenoxyphenyl)-methanesulphonamide |
51765-56-1 |
A |
- |
A |
- |
39 |
N-(2-phenoxyphenyl)-methanesulphonamide |
51765- 51-6 |
B |
- |
B |
- |
40 |
2-phenoxyaniline |
2688-84-8 |
C |
- |
C |
- |
41 |
4-nitro-2-phenoxyphenol |
70995-08-3 |
D |
- |
D |
- |
42 |
N,N’-(bis methylsulfonyl)-2-phenoxy aniline |
905858-63-1 |
E |
- |
E |
- |
43 |
N,N’-(bis methylsulfonyl)-2-phenoxy-4-nitro aniline |
51765-72-1 |
F |
- |
F |
- |
|
PIPERAQUINE PHOSPHATE* |
44 |
7-chloro-4-piperazinyl quinoline |
837-52-5 |
- |
- |
- |
- |
45 |
1,4-bis-(4,7-dichloroquinoline)piperazine |
- |
- |
- |
- |
- |
46 |
4-Piperazin-7-chloro-quinoline |
- |
- |
A |
- |
- |
47 |
7-Chloro-4-{4-[3-(piperazin-1-yl)propyl]piperazin-1-yl}quinoline |
4039-00-3 |
- |
B |
- |
- |
48 |
5-Chloro-4-(4-{3-[4-(7-chloroquinolin-4-yl)piperazin-1-yl] propyl}piperazin-1-yl)quinoline |
918879-09-1 |
- |
C |
- |
- |
49 |
7-Chloroquinolin-4-ol |
86-99-7 |
- |
D |
- |
- |
50 |
4,4’-[Piperazine-1,4-diylbis(propane-3,1-diylpiperazine-4,1-diyl)]bis(7-chloroquinoline). |
86486-21-7 |
- |
E |
- |
- |
51 |
7-Chloro-4-(4-{3[(7-chloroquinolin-4-yl)oxy]propyl} piperazin-1-yl)quinoline |
1233345-93-1 |
- |
F |
- |
- |
52 |
N-(7-Chloroquinolin-4-yl)-N’-{3-[4-(7-chloroquinolin-4-yl) piperazin-1-yl]propyl}ethane-1,2-diamine |
- |
- |
G |
- |
- |
53 |
4,4’-Piperazine-1,4-diylbis(7-chloroquinoline) |
- |
- |
H |
- |
- |
54 |
7-Chloro-4-[4-(3-chloropropyl)piperazin-1-yl]quinoline |
4038-99-7 |
- |
I |
- |
- |
|
TENOFOVIR DISOPROXIL FUMARATE* |
55 |
Tenofovir or (R)-[1-(6-Amino-9H-purin-9-yl) propan-2-yloxy] methyl phosphonic acid |
147127-20-6 |
- |
- |
- |
- |
56 |
Adenine or 9H-purin-6-amine |
73-24-5 |
- |
- |
- |
- |
57 |
Tenofovir disoproxil impurity A or Tenofovir related compound A or (S)-5-[[2-(6-Amino-9H-purin-9-yl)-1-methylethoxy] methyl]-2, 4, 6, 8-tetraoxa-5-phosphanonanedioic acid, bis (1-methylethyl) ester, 5-oxide, (E)-2-butenedioate (1:1). or S-isomer of Tenofovir disoproxilfumarate. |
- |
- |
A |
- |
- |
58 |
(R)-9-(2-Hydroxypropyl)adenine or HPA |
14047-28-0 |
- |
- |
- |
- |
59 |
Tenofovir isoproxil monoester OR ({[(R) -1-(6-Amino-9H-purin-9-yl) propan-2-yloxy] methyl} (hydroxy) phosphoryloxy) methyl isopropyl carbonate |
211364-69-1 |
- |
- |
- |
- |
60 |
Des methyl Tenofovir Disoproxil OR O,O-Bis (isopropylcarbonyloxymethyl) [(6-amino-9H-purin-9yl)ethyloxy]methyl phosphonate |
365417-53-4 |
- |
D (As Procedure-2) |
- |
- |
61 |
Diethyl (tosyloxy) methyl phosphonate OR Diethoxy phosphoryl Tosylate |
31618-90-3 |
- |
- |
- |
- |
|
EMTRICITABINE* |
Sr. No. |
Name |
CAS No. |
BP Code |
USP Code |
EP Code |
WHO Code |
62 |
cis-5-[4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl]-1,3-oxathiolane-2-carboxylic acid (Emtricitabine acid) |
1238210-10-0 |
- |
B |
- |
A |
63 |
4-Amino-5-fluoropyrimidin-2(1H)-one (Fluoro cytosine) |
2022-85-7 |
- |
A |
- |
E |
64 |
L-Menthyl 5-(2R,5S)-[4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl]-1,3-oxathiolane-2-carboxylate (F-CME) |
764659-72-5 |
- |
G |
- |
- |
65 |
(2R,5R)-5-Hydroxy-1,3-oxathiolane-2-carboxylic acid (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester (HME) |
147126-62-3 |
- |
- |
- |
- |
66 |
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxy methyl)-1, 3-oxathiolan-5-, (2R-cis)-; or (-)-1-[(2R, 5S)-2-(Hydroxymethyl)-1, 3-oxathiolan-5-cytosine. (Des Fluoro Emtricitabine) |
34678-17-4 |
- |
D |
- |
C |
67 |
Benzoic acid, 2-hydroxy-. (salicylic acid) |
69-72-7 |
- |
F |
- |
- |
|
PRIMAQUINE PHOSPHATE |
Sr. No. |
Name |
CAS No. |
BP Code |
USP Code |
EP Code |
WHO Code |
68 |
6-Methoxy-8-amino quinoline (Primaquine phosphate impurity-1: Specified unidentified impurity; RRT.-0.24) |
90-52-8 |
- |
Imp. at RRT.-0.24 |
- |
- |
69 |
2,3-Dihydrophthalazine-1,4-dione (Primaquine phosphate impurity-2: Specified unidentified impurity; RRT.-0.29) |
1445-69-8 |
- |
Imp. at RRT.-0.29 |
- |
- |
70 |
2-(4-Bromopentyl)isoindoline 1,3-dione or 4-Bromo-1-phthalimido pentane (4-BPP) |
59353-62-7 |
- |
- |
- |
- |
71 |
Potassium phthalimide |
1074-82-4 |
- |
- |
- |
- |
72 |
1,4-dibromopentane |
626-87-9 |
- |
- |
- |
- |
73 |
2-(4-((6-methoxyquinolin-8-yl)amino)pentyl)isoindoline-1,3-dione sulfate [Isoindoline-1,3-dione] |
- |
- |
- |
- |
- |
74 |
Bis isoindoline-1,3 dione impurity OR 2,2'-(pentane-1,4-diyl)bis(isoindoline-1,3-dione)
|
- |
- |
- |
- |
- |
75 |
3-Nitro-4-acetyl amino anisole or N-(4-methoxy-2-nitrophenyl)acetamide |
119-81-3 |
- |
- |
- |
- |
76 |
4-Methoxyacetanilide or N-(4-methoxyphenyl)acetamide |
51-66-1 |
- |
- |
- |
- |
77 |
4-Methoxy-2-Nitroaniline |
96-96-8 |
- |
- |
- |
- |
78 |
6-methoxy-8-nitroquinoline |
85-81-4 |
- |
- |
- |
- |
79 |
N-(6-methoxyquinolin-8-yl)hydroxylamine |
57742-99-1 |
- |
- |
- |
- |
|
EFAVIRENZ* |
Sr. No. |
Name |
CAS No. |
BP Code |
USP Code |
EP Code |
WHO Code |
80 |
USP EfavirenzRacemic mixture RS or
(RS)-6-Chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1H-benzo[d][1,3]oxazine-2(4H)-one
|
177530-93-7 |
- |
USP Efavirenz Racemic mixture Rs |
- |
- |
81 |
Efavirenz amino alcohol (Efavirenz amino carbinol) or
(S)-2-(2-Amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3yn-2-ol |
209414-27-7 |
- |
A |
- |
E |
82 |
N-Benzyl efavirenz OR (S)-6-chloro-4-(cyclopropylethynyl)-1-(4-methoxybenzyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one |
174819-21-7 |
- |
I |
- |
D |
83 |
Efavirenz benzoyl amino alcohol OR (S)-N-(4-chloro-2-(4-cyclopropyl-1, 1, 1-trifluoro-2-hydroxybut-3-yn-2-yl) phenyl)-4-methoxy benzamide |
- |
- |
J |
- |
A |
84 |
Quinoline analog OR 6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline |
391860-73-4 |
- |
K |
- |
F |
85 |
Efavirenz amino alcohol ethyl carbamate OR
(S)-Ethyl 4-chloro-2-(4-cyclopropyl-1, 1, 1-trifluoro-2-hydroxybut-3-yn-2-yl) phenylcarbamate |
- |
- |
L |
- |
- |
86 |
Efavirenz amino alcohol bis(ethoxycarbonyl)OR (S)-Ethyl 4-chloro-2-(4-cyclopropyl-2-(ethoxycarbonyloxy)-1, 1, 1-trifluorobut-3-yn-2-yl) phenylcarbamate |
- |
- |
N |
- |
- |
87 |
Efavirenz amino alcohol methyl carbamate or
(S)-methyl 4-chloro-2-(4-cyclopropyl-1,1,1-trifluoro-2-hydroxybut-3-yn-2-yl)phenyl carbamate |
211563-41-6 |
|
H |
- |
H |
88 |
4-Chloro-2-trifluoroacetyl aniline hydrochloride hydrate (Keto aniline OR E-2) |
173676-59-0 |
- |
- |
- |
- |
|
LAMIVUDINE* |
Sr. No. |
Name |
CAS
No. |
BP
Code |
USP
Code |
EP
Code |
WHO
Code |
89 |
(2RS, 5RS)-5-(4-aminp-2-oxopyrimidine-1(2H)-yl)-1,3-oxathiolane-2-carboxylicacid OR Lamivudine acid impurity |
173829-09-9 |
- |
Specified imp.-1 |
A |
A |
90 |
4-aminopyrimidin-2(1H)-one OR cytosine |
71-30-7 |
- |
- |
E |
E |
91 |
Pyrimidine-2,4-(1H, 3H)-dione OR Uracil |
66-22-8 |
- |
- |
F |
F |
92 |
1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolane-5-yl]pyrimidine-2,4-(1H,3H)-dione OR Lamivudine uridine analogue
|
145986-07-8 |
- |
- |
J |
J |
93 |
(2R,5S)-(1R,2S,5R)-2-iso propyl-5-methylcyclo hexyl 5-(4-amino-2-oxo pyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate (CME)
|
147027-10-9 |
- |
- |
- |
- |
|
ATAZANAVIR SULFATE* |
Sr. No. |
Name |
CAS
No. |
BP
Code |
USP
Code |
EP
Code |
WHO
Code |
94 |
tert-butyl ((S)-1-((R)-oxiran-2-yl)-2-phenylethyl)carbamate (Boc Epoxy) |
98760-08-8 |
- |
- |
- |
- |
95 |
tert-butyl 2-((2S,3S)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-4-phenylbutyl) -2-(4-(pyridin-2-yl)benzyl)hydrazinecarboxylate or Des-N-(methoxycarbonyl)-L-tert-Leucine-Bis Boc Atazanavir orAtazanavir di-tert-butyl analog |
198904-86-8 |
- |
- |
- |
- |
96 |
(S)-2-((methoxycarbonyl)amino)-3,3-dimethylbutanoic acid orMethoxycarbonyl-L-tert-Leucine OR MOC-L-tert-Leucine ORAtazanavir Related compound A |
162537-11-3 |
- |
- |
- |
- |
97 |
1H-benzo[d][1,2,3]triazol-1-ol hydrate (HOBT monohydrate) |
123333-53-9 |
- |
- |
- |
- |
98 |
4-(2-Pyridinyl)benzaldehyde OR Pyridinyl benzaldehyde |
127406-56-8 |
- |
- |
- |
- |
99 |
tert-butyl 2-(4-(pyridin-2-yl)benzyl) hydrazine carboxylate (Boc Hydrazine) |
198904-85-7 |
- |
- |
- |
- |
100 |
(2S, 3S)-1,2-epoxy-3-(Boc-amino)-4-phenyl butane OR (2S,3S)-Boc epoxy
OR Boc-epoxy diastereomer impurity |
98737-29-2
|
- |
- |
- |
- |
101 |
N'-(4-PYRIDIN-2-YL-BENZYLIDENE)-HYDRAZINECARBOXYLIC ACID _TERT_-BUTYL
ESTER OR _TERT_-BUTYL
[[4-(2-PYRIDINYL)PHENYL]METHYLENE]HYDRAZINECARBOXYLATE OR IMPURITY-A OF
BOC-HYDRAZINE OR BOC-HYDRAZINE (N-1 IMPURITY) |
198904-84-6
|
- |
- |
- |
- |
102 |
1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Hydrochloride (EDC.HCl) |
25952-53-8 |
- |
- |
- |
- |
103 |
Racemic mixture (DL) of Methoxy carbonyl-L-tert-Leucine or Methoxy carbonyl-DL-tert-Leucine |
- |
- |
- |
- |
- |
104 |
4-(Pyridin-2-yl)benzoic acid OR 4-(2-Pyridyl)benzoic acid or Pyridinyl benzoic acid |
4385-62-0 |
- |
- |
- |
- |
105 |
1-[4-(Pyridin-2-yl)phenyl]-5(S)-2,5-bis{[N-(methoxy-carbonyl)-D-tert-leucinyl]amino}-4(S)-hydroxy-6-phenyl-2-azahexane or Atazanavir diastereomer R, S, S, R |
1292296-11-7 |
- |
- |
- |
- |
106 |
1-[4-(Pyridin-2-yl)phenyl]-5(S)-2,5-bis{[N-(methoxy-carbonyl)-L-tert-leucinyl]amino}-4(R)-hydroxy-6-phenyl-2-azahexane or Atazanavir diastereomer S, S, R, S |
1292296-09-3 |
- |
- |
- |
- |
107 |
1-[4-(Pyridin-2-yl)phenyl]-5(S)-2,5-bis{[N-(methoxy-carbonyl)-D-tert-leucinyl]amino}-4(R)-hydroxy-6-phenyl-2-azahexane or Atazanavir diastereomer R, S, R, R |
- |
- |
- |
- |
- |
|
SOFOSBUVIR* |
Sr. No. |
Name |
CAS
No. |
BP
Code |
USP
Code |
EP
Code |
WHO
Code |
108 |
1-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetra hydrofuran-2~yl)pyrim idine-2,4(1H,3H)-dione or SFB Uridine or 2’-deoxy-2’-fluoro-2’-C-methyluridine |
817204-32-3 |
- |
- |
- |
- |
109 |
Isopropyl ((S)-2-(((2R,3R,4R,5R)-5-(2,4-dioxo~3 ,4-dlhydropyrlmidin- 1 (2H)-yl )-4-fluoro~2-((((S)-(((S)- 1 -i sopropoxy-1 -oxopropan-2- yl)amino)(phenoxy) phosphoryl)oxy)methyl)-4-methyltetrahydrofuran- 3-yl)oxy) (phenoxy)phosphory1)-L-a1aninate or SFB Dimer |
1337482-17-3 |
- |
- |
- |
- |
110 |
Isopropyl ((S)-(pertluorophenoxy)(phenoxy)phosphoryi)-L-alaninate or SFB-C or N-[(s)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine-1-methylethyl ester |
1334513-02-8 |
- |
- |
- |
- |
111 |
2, 3, 4, 5, 6-pentafluorophenolOR Pentafluoro phenol |
771-69-1 |
- |
- |
- |
- |
|
SULFADOXINE* |
Sr. No. |
Name |
CAS
No. |
BP
Code |
USP
Code |
EP
Code |
WHO
Code |
112 |
Sulfanilamide or 4-aminobenzenesulfonamide |
63-74-1 |
- |
- |
- |
A |
113 |
4, 6-Dichloro-5-methoxy pyrimidine |
5018-38-2 |
- |
- |
- |
- |
114 |
4-amino-N-(6-chloro-5-methoxypyrimide-4-yl) benzenesulfonamide or 4-Amino-N-(6-chloro-5-methoxy-4-pyrimidinyl) benzenesulfonamide |
5018-23-5 |
- |
- |
- |
- |
115 |
N-(4-(N-(5,6-dimethoxypyrimidin-4-yl) sulfamoyl)phenyl)acetamide OR Impurity-C |
5018-54-2 |
- |
- |
- |
C |
116 |
5,6-dimethoxypyrimidin-4-amine OR Impurity-D |
5018-45-1 |
- |
- |
- |
D |
117 |
Sodium 5-methoxypyrimidine-4,6-bis(olate) or SMPB |
5193-84-0 |
- |
- |
- |
- |
|
PYRIMETHAMINE* |
Sr. No. |
Name |
CAS
No. |
BP
Code |
USP
Code |
EP
Code |
WHO
Code |
118 |
Pyrimethamine EP Impurity-A or 2-(4-chlorophenyl)-3-oxopentanenitrile. |
55474-40-3 |
- |
- |
A |
- |
119 |
Pyrimethamine EP Impurity-B or 5-(4-chlorophenyl)-6-methylpyrimidine-2,4-diamine |
3275-44-3 |
- |
- |
B |
- |
120 |
Pyrimethamine EP Impurity-C or (4-chlorophenyl) acetonitrile |
140-53-4 |
- |
- |
C |
- |
121 |
Pyrimethamine EP Impurity-D or (4-chlorophenyl)(2-ethyl-1,3-dioxolan-2-yl) acetonitrile |
55474-41-4 |
- |
- |
D |
- |
122 |
4-methylbenzenesulfonic acid or p-Toluene sulfonic Acid mono hydrate |
6192-52-5 |
- |
- |
- |
- |
123 |
Pyrimethamine ortho isomer impurity or 5-(2-chlorophenyl)-6-ethylpyrimidine-2,4-diamine |
- |
- |
|
- |
- |
|
TENOFOVIR ALAFENAMIDE HEMIFUMARATE* |
Sr. No. |
Name |
CAS
No. |
BP
Code |
USP
Code |
EP
Code |
WHO
Code |
124 |
(2S, 2'S)-diisopropyl 2,2'-((((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(azanediyl))dipropanoate or PMPA Bisamidate |
1883563-86-7 |
- |
- |
- |
- |
125 |
Phenyl hydrogen ((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonate OR Monophenyl PMPA |
379270-35-6
|
- |
- |
- |
- |
126 |
Phenol OR Benzenol |
108-95-2 |
- |
- |
- |
- |
127 |
4-Dimethyl amino pyridine OR Dimethylamino pyiridine |
1122-58-3 |
- |
- |
- |
- |
128 |
(S)-2-Aminopropionic acid OR L-α-Aminopropionic acid OR L-Alanine |
56-41-7 |
- |
- |
- |
- |
129 |
(S)-2-Amino-propionic acid isopropyl ester OR L-Alanine isopropyl ester HCl |
62062-65-1 |
- |
- |
- |
- |
130 |
Tenofovir Alafenamide System Suitability Mixture OR Tenofovir Alafenamide
(Ps): Diastereomer (PR) |
- |
- |
- |
- |
- |
|
DOLUTEGRAVIR SODIUM* |
Sr. No. |
Name |
CAS
No. |
BP
Code |
USP
Code |
EP
Code |
WHO
Code |
131 |
Diacetal-3-carboxylic acid impurity OR 1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo- 1,4-dihydropyridine-3-carboxylic acid |
1335210-23-5 |
- |
- |
- |
- |
134 |
[1,3] Oxazine acid impurity OR (4R,12aS)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido [1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid |
1335210-34-8 |
- |
- |
- |
- |
135 |
[1,3] Oxazine Amide impurity OR (4R,12aS)-N-(2,4-difluorobenzyl)-7-methoxy-4,12a-dimethyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
1335210-35-9 |
- |
- |
- |
- |
136 |
2-desfluoro hydroxy impurity OR (4R,12aS)-N-(4-fluorobenzyl)-7-hydroxy-4,12a-dimethyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
1863916-88-14 |
- |
- |
- |
- |
137 |
4-desfluoro methoxy impurity OR (4R,12aS)-N-(2-fluorobenzyl)-7-hydroxy-4,12a-dimethyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
1863916-87-3 |
- |
- |
- |
- |
138 |
2,4-di desfluoro methoxy impurity OR (4R,12aS)-N-benzyl-7-hydroxy-4,12a-dimethyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
- |
- |
- |
- |
- |
139 |
(4R,12aS)-N-(4-fluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8, 12,12a-hexahydro-2H-pyrido[1',2':4,5] pyrazino[2,1-b][1,3]oxazine-9-carboxamide OR 2-Des fluoro methoxy |
- |
- |
- |
- |
- |
140 |
(4R,12aS)-N-(2-fluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8, 12,12a-hexahydro-2H-pyrido[1',2':4,5] pyrazino[2,1-b][1,3]oxazine-9-carboxamide or 4-Des fluoro Dolutegravir |
1863916-87-3 |
- |
- |
- |
- |
141 |
(4S,12aR)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6 ,8,12,12a-hexahydro-2H-pyrido[1',2':4,5] pyrazino[2,1-b][1,3] oxazine-9-carboxamide or Dolutegravir Enantiomer (S, R) |
1309560-49-3 |
- |
- |
- |
- |
142 |
Racemic mixture of Dolutegravir [R,S] and Diastereomer [R,R] |
- |
- |
- |
- |
- |
143 |
Racemic mixture of (S) 3-amino-1-butanol : (R) 3-amino-1-butanol |
- |
- |
- |
- |
- |
144 |
Methyl 4-methoxy-3-oxobutanoate |
41051-15-4 |
- |
- |
- |
- |
145 |
(Z)-methyl 2-(((2,2-dimethoxyethyl)amino)methylene)-4-methoxy-3-oxobutanoate |
1335210-26-8 |
- |
- |
- |
- |
146 |
Dimethyl-1-(2,2-Dimethoxyethyl)-3-methoxy-4-oxo-1,4-dihydropyridine-2,5-dicarboxylate |
1646862-02-3 |
- |
- |
- |
- |
147 |
(4R, 12aS)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-Pyrido[1',2',4,5]pyrazino[2,1-b][1,3 ]oxazine-9-Carboxylic acid |
1246616-73-8 |
- |
- |
- |
- |
148 |
N-(2,4-Difluorobenzyl)-9-hydroxy-2-(4-hydroxy butan-2-yl)-1,8-dioxo-1,8-dihydro-2H-pyrido [2,1-a]pyrazine-7-carboxamide |
1973402-05-9 |
- |
- |
- |
- |
|
PREGABLIN* |
Sr. No. |
Name |
CAS
No. |
BP
Code |
USP
Code |
EP
Code |
WHO
Code |
149 |
Lactum impurity or (4S)-4-(2-methylpropyl)pyrrolidin-2-one |
61312-87-6 |
- |
C |
A |
- |
150 |
Mandelic acid impurity or (2RS)-2-hydroxy-2-phenylacetic acid |
90-64-2 |
- |
- |
C |
- |
151 |
Pregabalin Racemic mixture or 3-(Amino methyl)-5-methylhaxanoic acid |
128013-69-4 |
- |
- |
B |
- |
152 |
(R)-()-3-(carbamoyl methyl) -5-methyl hexanoic acid (R-CMH) |
181289-33-8 |
- |
- |
- |
- |
153 |
(+)-3-Carbamoymethyl-5-methylhexanoic acid (CMH) |
181289-15-6 |
- |
- |
- |
- |
154 |
1-methylethyl (2RS)-2-hydroxy-2-phenylacetate |
4118-51-8 |
- |
- |
D |
- |
155 |
(R)-()-3-(carbamoyl methyl)-5-methyl hexanoic acid or R-CMH system suitability mixture |
- |
- |
- |
- |
- |
156 |
R-CMH Impurity-A or 3-isobutylglutaric acid or 3-isobutylpentanedioic acid or 3-(2-methylpropyl) pentanedioic Acid |
75143-89-4 |
- |
- |
- |
- |
157 |
R-CMH Impurity-B or D-α-Methylbenzylamineor(R)-(+)-1-Phenylethylamine |
3886-69-9 |
- |
- |
- |
- |
158 |
R-CMH Impurity-C or 4-(2-methylpropyl)piperidine-2,6-dione or 4-Isobutylpiperidine-2, 6-dione 3-Isobutylglutarimide. |
916982-10-0 |
- |
- |
- |
- |
|
ACYCLOVIR* |
Sr. No. |
Name |
CAS
No. |
BP
Code |
USP
Code |
EP
Code |
WHO
Code |
159 |
2-[[2-(Acetylamino)-6-oxo-1,6-dihydro-9H-purin-9-yl]methoxy]ethyl acetate OR 9-[(2-Acetoxyethoxy) methyl]-N2-acetyl guanine OR Diacetyl acyclovir OR Impurity-G |
75128-73-3 |
- |
- |
G |
G |
160 |
N-(9-acetyl-6-oxo-6,9-dihydor-1H-purin-2-yl)acetamide (N2, 9-diacetyl guanine) OR Diacetyl Guanine OR Impurity-L |
3056-33-5 |
- |
- |
L |
L |
161 |
2-Amino-1,7-dihydro-6H-purine OR 2-Amino-9H-purin-6 (1H)-one OR Guanine OR Impurity-B |
73-40-5 |
- |
- |
B |
B |
162 |
1,4-Diacetoxy-2-oxabutane or 2-[(2-Acetoxyethoxy)methoxy]-2-oxoethan-1-ylium or Dioxalane Diacetate |
59278-00-1 |
- |
- |
- |
- |
|
PYRONARIDINE TETRAPHOSPHATE* |
Sr. No. |
Name |
CAS
No. |
BP
Code |
USP
Code |
EP
Code |
WHO
Code |
163 |
2,4-Dichloro benzoic acid (DCBA) |
50-84-0 |
- |
- |
- |
- |
164 |
5-Amino-2-methoxy pyridine (AMP) |
6628-77-9 |
- |
- |
- |
- |
165 |
N-[4-Hydroxy-3,5-bis(pyrrolidin-1-yl methyl) phenyl]acetamide (HPPA) |
- |
- |
- |
- |
- |
166 |
4-Chloro-2-[(6-methoxypyridin-3-yl)amino]benzoic acid (CMBA) |
- |
- |
- |
- |
- |
167 |
7,10-Dichloro-2-methoxy-5,10-dihydrobenzo[b]-1,5-naphthydine (DCNM) |
- |
- |
- |
- |
- |
|
BICTEGRAVIR SODIUM* |
Sr. No. |
Name |
CAS
No. |
BP
Code |
USP
Code |
EP
Code |
WHO
Code |
168 |
6-Desfluoro Bictegravir Free acid (GS-626446) OR (2R,5S,13aR)-N-(2,4-difluorobenzyl)-8-hydroxy-7,9-dioxo-2,3,4,5, 7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b] [1,3]oxazepine-10-carboxamide
|
- |
- |
- |
- |
- |
169 |
Bictegravir Amide OR Methyl 1-(2,2-dimethoxyethyl)-3-methoxy-4-oxo-5-((2,4,6-trifluorobenzyl)carbamoyl)-1,4-dihydropyridine-2-carboxylate
|
1644158-10-0
|
- |
- |
- |
- |
170 |
Bictegravir Dihydroxy OR Methyl 1-(2,2-dihydroxyethyl)-3-methoxy-4-oxo-5-((2,4,6-trifluorobenzyl)carbamoyl)-1,4-dihydropyridine-2-carboxylate
|
- |
- |
- |
- |
- |
171 |
Bictegravir Methoxy OR (2R,5S,13aR)-8-methoxy-7,9-dioxo-N-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino [2,1-b][1,3]oxazepine-10-carboxamide |
- |
- |
- |
- |
- |
172 |
Bictegravir System suitability mixture (Bictegravir sodium and GS-652240)
|
- |
- |
- |
- |
- |
173 |
Open Ring Bictegravir Free acid (GS-649086) OR 9-hydroxy-2-((1S,3R)-3-hydroxy cyclopentyl)-1,8-dioxo-N-(2,4,6-trifluorobenzyl)-2,8-dihydro-1H-pyrido[1,2-a]pyrazine-7-carboxamide
|
- |
- |
- |
- |
- |
|
NITRO FURANTOIN* |
Sr. No. |
Name |
CAS
No. |
BP
Code |
USP
Code |
EP
Code |
WHO
Code |
174 |
1-Aminohydantoin Hydrochloride or 1-aminoimidazolidine-2,4-dione Hydrochloride
|
2827-56-7 |
- |
- |
- |
- |
175 |
5-Nitrofurfural Diacetate or (5-nitrofuran-2-yl) methylene Diacetate OR 5-Nitro-2-furaldehyde Diacetate
|
92-55-7 |
- |
- |
- |
- |
176 |
5-Nitrofurfural or (5-nitrofuran-2-carbaldehyde) or 5-Nitro-2-furaldehyde
|
698-63-5 |
- |
- |
- |
- |
177 |
Nitrofurazone or 2-[(5-Nitro-2-furyl) methylene] hydrazine carboxamide OR [(E)-(5-nitrofuran-2-yl) methylideneamino]urea |
59-87-0 |
- |
- |
- |
- |
|
ATORVASTATIN CALCIUM* |
Sr. No. |
Name |
CAS
No. |
BP
Code |
USP
Code |
EP
Code |
WHO
Code |
178 |
Atorvastatin-tert-butyl ester ;(3R,5R)-tert-butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxy heptanoate.
|
134395-00-9 |
- |
- |
- |
- |
179 |
Atorvastatin Acetonide tert-Butyl Ester (L1) tert-Butyl (4R,6R)-2-[[[6-(2-4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenyl carbamoyl) pyrrol-1-yl]ethyl]-2,2-di methyl-1, 3-dioxan-4-yl]acetate or (4r,6r)-6-[2-[2-(4-fluoro phenyl) -5-(1-methyl ethyl) - 3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetic acid 1,1-dimethyl ethyl ester or Atorvastatin intermediate L1 or Atorvastatin Acetonide tert-Butyl Ester or Atorvastatin Related Compound-I.
|
125971-95-1 |
- |
- |
- |
- |
180 |
Atorvastatin Impurity-M4 or (2-[2-(4-fluoro-phenyl)-2-oxo-1-phenyl-ethyl]-4-methyl-3-oxo-pentanoicacid phenyl amide (M4)
|
125971-96-2 |
- |
- |
- |
- |
|
FAVIPIRAVIR* |
Sr. No. |
Name |
CAS
No. |
BP
Code |
USP
Code |
EP
Code |
WHO
Code |
181 |
6-Bromo-3-hydroxypyrazine-2-carboxamide
|
259793-88-9 |
- |
- |
- |
- |
182 |
3,6-Dichloropyrazine-2-carbonitrile
|
356783-16-9 |
- |
- |
- |
- |
183 |
6-fluoro-3-hydroxypyrazine-2-carboxylic acid OR Favipiravir acid impurity
|
1079990-21-8 |
- |
- |
- |
- |
184 |
6-Fluoro-3-hydroxypyrazine-2-carbonitrile dicyclo hexylamine salt
|
1137606-74-6 |
- |
- |
- |
- |
|
ISONIAZID* |
Sr. No. |
Name |
CAS
No. |
BP
Code |
USP
Code |
EP
Code |
WHO
Code |
185 |
Pyridine-4-carboxylic acid or Isonicotinic acid or Isoniacin
|
55-22-1 |
A |
- |
- |
- |
186 |
Pyridine-4-Carboxamide or Isonicotinamide
|
1453-82-3 |
B |
- |
- |
- |
187 |
4-Cynopyridine, Pyidine-4-carbonitrile or Isonicotnonitrile
|
100-48-1 |
C |
- |
- |
- |
188 |
Pyridine-3-carbohydrazine or Nicotinoyl hydrazine |
553-53-7 |
D |
- |
- |
- |
189 |
2-Cynopyridine, Pyidine-2-carbonitrile or Picolinonitrile or 2-Isoniazid |
100-70-9 |
- |
- |
- |
- |
190 |
3-Cynopyridine, Pyidine-3-carbonitrile or 3-Isoniazid |
100-54-9 |
- |
- |
- |
- |
191 |
Pyridine-2-carbohydrazine or Picolino hydrazine
|
1452-63-7 |
- |
B |
- |
- |
|
PARACETAMOL* |
Sr. No. |
Name |
CAS
No. |
BP
Code |
USP
Code |
EP
Code |
WHO
Code |
192 |
Paracetamol Impurity-F or 4-Nitrophenol or p-nitro phenol
|
100-02-7 |
- |
- |
- |
- |
193 |
Paracetamol Impurity-J or 4-chloro acetanilide or p-chloro acetanilide
|
539-03-7 |
- |
- |
- |
- |
194 |
Paracetamol Impurity-K or 4-aminophenol or p-amino phenol
|
123-30-8 |
- |
- |
- |
- |
|
ETODOLAC* |
Sr. No. |
Name |
CAS
No. |
BP
Code |
USP
Code |
EP
Code |
WHO
Code |
195 |
Tryptophol |
526-55-6 |
- |
- |
- |
- |
196 |
7-Ethyl tryptophol (7-ETP) OR 2-(7-ethyl-1H-indol-3-yl) ethanol |
41340-36-7 |
- |
- |
H |
- |
197 |
(1RS)-8-ethyl-1-methyl-1,3,4,9-tetrahydropyrano[3,4-b] indol-1-yl] acetic acid (as per EP) OR (+/-)-8-Ethyl-1-methyl-1,3,4,9-tetrahydropyrano [3,4-b]-indole-1-acetic acid (as per USP) OR 1-Methyl etodolac |
109518-47-0 |
- |
Related Compd. A |
C |
- |
198 |
Methyl [(1RS)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b] indol-1-yl] acetate (as per EP) OR Etodolac Methyl Ester
|
122188-02-7 |
- |
- |
K |
- |
|
* Standard of API is also available |
|